Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Published Date: 14-Sep-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3363 Status : Published

Global thrombosis drug market expected to generate revenue of around USD 40934.75 million by end of 2024, growing at a CAGR of around 9.3% between 2018 and 2024. Thrombosis is a blood clot in the veins or arteries obstructing the blood flow in the circulatory system. It may be formed due to injury or some other reasons.

Request Free Brochure of Thrombosis Drug Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social